Manon MJ Cox, PhD, MBA
Message from the ISV President (ISV President, 2026-2027)
I am delighted to serve as your 2026 and 2027 President of the International Society for Vaccines (ISV). Our Society brings together colleagues from all over the world and aims to encourage, establish, and promote the development and use of vaccines and immuno-therapeutics to prevent and control infectious and non-infectious diseases in animals and humans.
I would like to begin by thanking our outgoing 2024 and 2025 Officers, Denise Doolan (Past President), Lenny Moise (Treasurer) and Joon Haeng Rhee (Secretary). It has been a pleasure serving with you on the executive committee. I want to thank Linda Klavinskis (now Past President) for doing a splendid job leading our Society during the past two years together with Jeffrey Ulmer, who served as our Vice Board Chair and who will return as Treasurer. In addition, I would like to welcome our new Officers: Indresh Srivastava (President-elect), and Lakshmi Krishnan (General Secretary).
I am also grateful for all the energy, insights and work done by our 2024 and 2025 departing Board Members, Neil Almond, Shan Lu, Ed Rybicki and David Weiner, most of whom will remain actively involved in our committees. I am looking forward to working with newly elected members Alejandra Capozzo, Branka Grubor-Bauk, Lars Frelin, Ab Osterhaus, and Baik-Lin Seong, in addition to our continuing Board members Annaliesa Anderson, Danilo Casimiro, Denise Doolan, Margaret Liu, and Michael Schotsaert.
Besides the Executive Committee and Board, we are fortunate to have an amazing group of talented highly motivated individuals working alongside ISV Officers and Board Members in various committees to fulfill our mission.
I am looking forward to working with our talented administrative staff Ted Gibson and Anna Taliadoros, who are essential in supporting all our activities.
ISV News & Insights
President’s End-of-Term Report (Jan. 2024 – Dec. 2025)
Linda S. Klavinskis, PhD
(ISV President 2024-2025)
Professor of Viral Immunology,
Department of Infectious Diseases,
King’s College London
As the 2024–2025 presidential term comes to a close, I am delighted to celebrate a period of remarkable growth, achievement, and global impact for the International Society for Vaccines (ISV), and thank all who were involved in contributing to these successes and to our members who actively engaged in ISVs activities to advance vaccine science worldwide.
It has been a great honour to serve as the President and to work alongside such an inspiring, dedicated, and passionate global community.
My term has been defined by new initiatives, global collaboration, and a shared commitment to excellence, guided by the missions I set out in January 2024 to advance our society and strengthen its global impact. Here’s a snapshot of what we have achieved together:
- Expanding ISV’s Scientific Activities.
We successfully launched monthly vaccine science webinars and quarterly themed mini-symposia, engaging members beyond our Annual Congress. These sessions showcased topics from mechanistic vaccinology to clinical trials and vaccine manufacturing and brought together leading experts worldwide. Importantly, by making all sessions available on the ISV YouTube channel, we extended the reach and impact of our science, ensuring ongoing access for members across the globe.
- Expanding ISV’s Global Outreach and Inclusivity.
Another important success of this term was the strengthening of ISV’s Global Partnerships and Organizational Foundations, led by Dr Shan Lu (Worchester HIV). Through enhanced collaboration with international vaccine organizations and societies (e.g., International AIDS Society, International Vaccine Institute, IVVN, VITAL-Korea, Butantan Institute and more), ISV expanded joint programming, co-hosted scientific sessions, and increased its visibility within the global vaccine ecosystem.
The 2025 ISV Annual Congress in Stellenbosch, South Africa likewise represented a major milestone as the Society’s first Annual Congress on the African continent. This achievement underscored ISV’s commitment to geographic inclusivity and global representation in vaccine science. The introduction of an Africa Day Satellite Meeting organised by Dr Ed Rybicki (University of Cape Town) and Dr Neil Almond (MHRA, UK) further strengthened regional engagement by highlighting locally driven research, manufacturing, and implementation efforts, while fostering meaningful dialogue between African and global vaccine stakeholders.
ISV December Webinar Recording Now Available!
Missed our December webinar? You can now watch the full recording on our YouTube channel.
Vaccines in the Era of Artificial Intelligence.
Rino Rappuoli, Biotecnopolo di Siena Foundation, Italy
Access the recording here.
December 2025 – ISV Paper of the Month
We are pleased to present our December Paper of the Month: “Assessing AI’s cognitive abilities for scientific discovery in the field of systems vaccinology” by Lucie Rodriguez-Coffinet, Dmitri Kazmin & Bali Pulendran, published in Science Immunology.
Read more here.
ISV 2025 Annual Congress Highlights
ISV Annual Congress
Africa Day Satellite Meeting
ISV 2025 Annual Congress
Bright Sparks and Poster Presenter AwardsCongratulations to all winner!
2025 ISV Congress Awards
The 2025 ISV Congress celebrated the achievements of leading scientists and contributors in the field of vaccines.
Congratulations to all awardees!
ISV Annual Supporters
Partners
Gold
Silver
Other
2025 ISV Annual Congress Exhibitors
